Background: In type 2 diabetes mellitus (DM) lipoprotein abnormalities are the main
contributors resulting high atherogenic dyslipidaemia. Non-HDL-cholesterol could be
used in screening patients with diabetes, especially in whom LDL-cholesterol levels
may not be significantly elevated.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Metabolism - Clinical and ExperimentalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
